Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71626 - 71650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	METRNL	284207	upregulated	Silicon Dioxide analog results in increased expression of METRNL mRNA	17q25.3	A24195
Silicon dioxide	Approved	METTL1	4234	upregulated	Silicon Dioxide analog results in increased expression of METTL1 mRNA	12q14.1	A24195
Silicon dioxide	Approved	METTL12	751071	upregulated	Silicon Dioxide analog results in increased expression of METTL12 mRNA	11q12.3	A24195
Silicon dioxide	Approved	METTL21A	151194	upregulated	Silicon Dioxide analog results in increased expression of METTL21A mRNA	2q33.3	A24195
Silicon dioxide	Approved	METTL7A	25840	downregulated	Silicon Dioxide analog results in decreased expression of METTL7A mRNA	12q13.12	A24195
Silicon dioxide	Approved	METTL7A	25840	downregulated	Silicon Dioxide results in decreased expression of METTL7A mRNA	12q13.12	A24197
Silicon dioxide	Approved	METTL7B	196410	downregulated	Silicon Dioxide analog results in decreased expression of METTL7B mRNA	12q13.2	A24195
Silicon dioxide	Approved	MEX3C	51320	upregulated	Silicon Dioxide analog results in increased expression of MEX3C mRNA	18q21.2	A24194
Silicon dioxide	Approved	MFAP2	4237	downregulated	Silicon Dioxide analog results in decreased expression of MFAP2 mRNA	1p36.13	A24195
Silicon dioxide	Approved	MFAP4	4239	downregulated	Silicon Dioxide analog results in decreased expression of MFAP4 mRNA	17p11.2	A24195
Silicon dioxide	Approved	MFAP5	8076	upregulated	Silicon Dioxide results in increased expression of MFAP5 mRNA	12p13.31	A24196
Silicon dioxide	Approved	MFNG	4242	upregulated	Silicon Dioxide results in increased expression of MFNG mRNA	22q13.1	A24196
Silicon dioxide	Approved	MFSD13A	79847	downregulated	Silicon Dioxide results in decreased expression of MFSD13A mRNA	10q24.32	A24196
Silicon dioxide	Approved	MGAM	8972	downregulated	Silicon Dioxide analog results in decreased expression of MGAM mRNA	7q34	A24195
Silicon dioxide	Approved	MGARP	84709	downregulated	Silicon Dioxide analog results in decreased expression of MGARP mRNA	4q31.1	A24194
Silicon dioxide	Approved	MGAT3	4248	downregulated	Silicon Dioxide analog results in decreased expression of MGAT3 mRNA	22q13.1	A24195
Silicon dioxide	Approved	MGAT3	4248	upregulated	Silicon Dioxide analog results in increased expression of MGAT3 mRNA	22q13.1	A24194
Silicon dioxide	Approved	MGAT4C	25834	upregulated	Silicon Dioxide analog results in increased expression of MGAT4C mRNA	12q21.31-q21.32	A24194
Silicon dioxide	Approved	MGEA5	10724	upregulated	Silicon Dioxide analog results in increased expression of MGEA5 mRNA	10q24.32	A24195
Silicon dioxide	Approved	MGST2	4258	downregulated	Silicon Dioxide analog results in decreased expression of MGST2 mRNA	4q31.1	A24195
Silicon dioxide	Approved	MIA2	4253	downregulated	Silicon Dioxide analog results in decreased expression of MIA2 mRNA	14q13.2	A24195
Silicon dioxide	Approved	MIAT	440823	downregulated	Silicon Dioxide analog results in decreased expression of MIAT mRNA	22q12.1	A24194 A24195
Silicon dioxide	Approved	MICALCL	84953	upregulated	Silicon Dioxide analog results in increased expression of MICALCL mRNA	11p15.3	A24194
Silicon dioxide	Approved	MICB	4277	upregulated	Silicon Dioxide analog results in increased expression of MICB mRNA	6p21.33	A24195
Silicon dioxide	Approved	MICB	4277	upregulated	Silicon Dioxide results in increased expression of MICB mRNA	6p21.33	A24196

Displaying entries 71626 - 71650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability